CS chains of serglycin are mainly responsible for binding to CD44 and collagen type I. Serglycin binding to CD44 most likely mediates the cell surface localization of serglycin [5, 7] that further interacts with matrix collagen type I thus promoting the adhesion of tumor cells [5, 11]. This evidence concerns the gene CD44 and neoplasm.